ReviewMolecular biology reports2025
Breathing new life into male fertility: the potential of mitochondrial transplantation.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male infertility affects about 7% of men worldwide. Along with this disease also comes stigma and taboo that overshadow its emotional and psychological impacts. Despite its widespread prevalence, many cases of male infertility remain idiopathic. This review illustrates the use of mitochondrial transfer in addressing male fertility issues, particularly in situations where sperm movement is hindered and there are problems with mitochondrial function. Various factors can trigger male infertility, such as problems with sperm quality or quantity, genetic disorders, hormonal imbalances, testicular injuries, infections, or lifestyle habits. Stress, anxiety, and depression are parameters that can make matters worse by disrupting hormone levels and sperm production. Currently, there's no reliable treatment for mitochondrial dysfunction, which plays a role in oxidative stress and lower ATP production. Mitochondrial transfer works by injecting healthy mitochondria into deficient cells; this, in turn, improves ATP production and reduces oxidative stress. This leads to improvements in sperm motility and viability. The technique has already been used and found effective in improving embryo quality in human oocytes, which shows its potential application in male infertility treatments. Therefore, in the present review, we discussed the mechanisms used for mitochondrial transfer, intercellular communication pathways, purification, and delivery techniques that can enhance therapeutic outcomes. By consolidating recent advances in this domain, we aim to present a comprehensive overview of mitochondrial transfer as an innovative intervention in the management of male infertility. The ultimate goal is to transform male infertility from a challenging condition into a manageable one. This will offer new hope to affected individuals and couples through advanced reproductive technologies and targeted therapeutic interventions.
Indexed as
Identifiers
41105314What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.